Oncology Market Research Report - Segmented By Cancer Type (Breast Cancer, Lung Cancer, Kidney Cancer, Liver Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Colorectal, Blood Cancer, Others); Therapy Type (Medical Oncology {Chemotherapy, Hormone Therapy, Targeted Therapy, Immune Therapy}, Radiation Oncology, Surgical Oncology, Others), Geography (North America, Europe, Asia Pacific, Rest of the World) - Size, Share, Trends, COVID-19 Impact and Growth Analysis Report - Industry Forecast (2022 to 2027)
Published: 2020 - June
Report Code: VMR-146
Format:
Region: Global
GLOBAL ONCOLOGY MARKET REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2022 – 2027 |
| Base Year | 2022 |
| Forecast Period | 2022 – 2027 |
| Segments Covered | By Cancer Type, Therapy Type, and Region |
| Regions Covered | North America, APAC, Europe, RoW |
CLICK HERE TO DOWNLOAD SAMPLE
Oncology Market – Forecast (2021-2026)
Chapter 1. Oncology Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Oncology Market – Executive Summary
2.1. Market Size & Forecast – (2021 – 2026) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2021 - 2026
2.3.2. Impact on Supply – Demand
2.3.3. Impact on Production Cost
2.3.4. Impact on Supply Chain
Chapter 3. Oncology Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Oncology Market Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Oncology Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Oncology Market – By Cancer Type
6.1. Breast Cancer
6.2. Lung Cancer
6.3. Kidney Cancer
6.4. Liver Cancer
6.5. Ovarian Cancer
6.6. Prostate Cancer
6.7. Skin Cancer
6.8. Pancreatic Cancer
6.9. Colorectal
6.10. Blood Cancer
6.11. Others
Chapter 7 . Oncology Market – By Therapy Type
7.1. Medical Oncology
7.1.1. Chemotherapy
7.1.2. Hormone Therapy
7.1.3. Targeted Therapy
7.1.4. Immune Therapy
7.2. Radiation Oncology
7.3. Surgical Oncology
7.4. Others
Chapter 8. Oncology Market , By Geography – Market Size, Forecast, Trends & Insights
8.1. North America
8.1.1. U.S.A
8.1.2. Canada
8.1.3. Mexico
8.2. Europe
8.2.1. Italy
8.2.2. Spain
8.2.3. Russia
8.2.4. Germany
8.2.5. UK
8.2.6. France
8.2.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Japan
8.3.2. South Korea
8.3.3. China
8.3.4. India
8.3.5. Australia & New Zealand
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. South America
Chapter 9. Oncology Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1. Company 1
9.2. Company 2
9.3. Company 3
9.4. Company 4
9.5. Company 5
9.6. Company 6
9.7. Company 7
9.8. Company 8
9.9. Company 9
9.10. Company 10
Download Sample
Choose License Type
2500
4250
5250
6900
